Ignite Creation Date:
2024-05-06 @ 7:25 PM
Last Modification Date:
2024-10-26 @ 3:06 PM
Study NCT ID:
NCT06006819
Status:
RECRUITING
Last Update Posted:
2023-08-23
First Post:
2023-08-17
Brief Title:
Prognostic Markers of Acute Heart Failure With Chronic Kidney Disease
Sponsor:
Cheng-Hsin General Hospital
Organization:
Cheng-Hsin General Hospital
Study Overview
Official Title:
Plasma Proteomic Signature and the Prognosis of Acute Heart Failure With or Without Chronic Kidney Disease
Status:
RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Acute heart failure AHF is defined as new or worsening of symptoms and signs of heart failure and is the most frequent cause of unplanned hospital admission in elderly patients N-terminal pro-brain natriuretic peptide NT-pro-BNP is one of the most developed prognostic markers for AHR patients and NT-pro-BNP has limitations in terms of diagnostic or predictive accuracy in patients with chronic kidney disease CKD Plasma proteomics have the potential to examine underlying pathophysiological and prognostic roles so we compared the plasma proteomic signature to predict outcomes of patients with or without CKD hospitalized for AHF
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None